Top conditions
Top treatments
Parent organization
This site is a part of Louisiana Heart Center
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...
This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left...
This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...
The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardi...
Clinical trials
Research sites
Resources
Legal